tesamorelin 11.6 MG Injection [Egrifta]

RxNorm concept 2719316, branded drug (sbd). Prescribable name: EGRIFTA WR 11.6 MG Injection.

RxCUI: 2719316
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2719316 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

tesamorelin 1044584

Other names

Egrifta 11.6 MG Injection

Related concepts

tesamorelin 11.6 MG (SCDC, consists of)
tesamorelin 11.6 MG [Egrifta] (SBDC, consists of)
Injection (DF, has dose form)
Egrifta (BN, has ingredient)
tesamorelin 11.6 MG Injection (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2719316 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2719316 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2719316. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.